Icon

PLEGINE (NDA012248)- (35MG)

PHENDIMETRAZINE TARTRATE WYETH AYERST
35MG
No No
Expired Expired
None None
None No
PLEGINE is indicated in the management of exogenous obesity as a short term adjunct (a few weeks) in a regimen of weight reduction based on caloric restriction in patients with an initial body mass index (BMI) of greater than or equal to 30 kg/m2 or greater than or equal to 27 kg/m2 in the presence of other risk factors (e.g., controlled hypertension, diabetes, hyperlipidemia) who have not responded to appropriate weight reducing regimen (diet and/or exercise) alone.
5 0 3
Total Other Developers None
Drugs with Suitability No
35MG ** ** - - 3
NDA Sales Available Total Generic Sales Available
No 3
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ***** **** *** ***** ************, ***. *********** ***\***\*** ****** ******, *********, *** ****** (**) *****, ****** ****** (***) ***
****** ****** **** ******, *** *********** ***** ***** ******* ******, *********, *** **** (**) *****, ****** ****** (***) ***
****** *** **** ***-****, ***. *********** *** ***** **., *******, ************ (**) *****, ****** ****** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.